Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Global Vitamin B1 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B1, or thiamin (thiamine), is a water-soluble vitamin found naturally in some foods, added to foods, and sold as a supplement. Vitamin B1 plays a vital role in the growth and function of vario...

December 2021 63 pages

Global Vitamin B12 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B12 is an important B vitamin. It is crucial for nerve tissue health, brain function, and the production of red blood cells. The global vitamin B12 market is projected to expand at a CAGR of ~...

December 2021 62 pages

Global Vitamin B6 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B6, or pyridoxine, is a water-soluble vitamin found naturally in many foods, as well as added to foods and supplements. According to latest analysis by Gen Consulting Company, the global vitam...

December 2021 61 pages

Global Vitamin B7 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B7, also known as biotin, vitamin H, is a water-soluble vitamin that helps the body metabolize fats, carbohydrates, and protein. Vitamin B7 supplements are often glamorized as a treatment for...

December 2021 73 pages

Global Vitamin B9 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B9, also called folate or folic acid, is one of 8 B vitamins. All B vitamins help the body convert food (carbohydrates) into fuel (glucose), which is used to produce energy. According to marke...

December 2021 60 pages

Global Vitamin B2 Market 2021 - Industry Statistics

US$ 750.00

Vitamin B2, or riboflavin, is one of eight B vitamins that are essential for human health. It is essential to the formation of two major coenzymes, flavin mononucleotide and flavin adenine dinucleotid...

December 2021 72 pages

Global Vitamin D3 Market 2021 - Industry Statistics

US$ 750.00

Vitamin D helps regulate the amount of calcium and phosphate in the body. These nutrients are needed to keep bones, teeth and muscles healthy. In humans, the most important compounds in this group are...

December 2021 65 pages

Global Vitamin E Market 2021 - Industry Statistics

US$ 750.00

Vitamin E is a group of eight fat soluble compounds that include four tocopherols and four tocotrienols. Vitamin E helps maintain healthy skin and eyes, and strengthen the body's natural defence again...

December 2021 66 pages

Global Antibiotics Market – Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)

US$ 2,400.00

Executive According to Azoth Analytics research report, the Global Antibiotic Market was valued at USD 46.66 Billion in the year 2020 with North America leading the regional market share. Growth in th...

November 2021 220 pages

Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifest...

November 2021 120 pages

Europe Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases...

November 2021 123 pages

Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity

US$ 2,720.00

Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases an...

November 2021 181 pages

North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity

US$ 2,295.00

North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifes...

November 2021 117 pages

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021

US$ 3,500.00

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 SUMMARY 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - 5?-Nucleotidase (5NT) i...

November 2021 145 pages

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021

US$ 2,000.00

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic...

November 2021 170 pages

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021

US$ 3,500.00

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021 SUMMARY Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Bcl-2-like protein 1 is a pro...

November 2021 66 pages

Bladder Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Bladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides...

November 2021 2564 pages

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Bullous Pemphigoid (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bullous Pemphigoid - Drugs In Development, 202...

November 2021 177 pages

Canavan Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Canavan Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Canavan Disease - Drugs In Development...

November 2021 35 pages

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Cell Division Cycle 7 Related Protein Kinase (CDC7 or EC 2.7.11.1) pipeline Target constitutes c...

November 2021 51 pages

Encephalopathy (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Encephalopathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Drugs In Development,...

November 2021 113 pages

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gastrointestinal Stromal Tumor (GIST) (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastrointestinal Stromal Tumor...

November 2021 866 pages

Gaucher Disease - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...

November 2021 143 pages

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Globoid C...

November 2021 79 pages

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Graves Diseases (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Drugs In Development, 20...

November 2021 102 pages

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Heart Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Heart Transplant Rejection - Drugs In D...

November 2021 40 pages

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

November 2021 157 pages

Huntington Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Huntington Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Huntington Disease - Drugs In Devel...

November 2021 423 pages

Hypertension (Cardiovascular) - Drugs in Development, 2021

US$ 2,500.00

Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...

November 2021 872 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021

US$ 3,500.00

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Integrin Alpha 4 - Drugs I...

November 2021 126 pages

Keloids (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...

November 2021 51 pages

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure - Drugs...

November 2021 143 pages

Macular Edema (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...

November 2021 102 pages

Melanoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...

November 2021 4610 pages

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metachromatic Leuko...

November 2021 51 pages

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis I - Dru...

November 2021 110 pages

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis II -...

November 2021 88 pages

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021

US$ 2,000.00

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis...

November 2021 115 pages

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Multiple Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis - Drugs In Devel...

November 2021 1320 pages

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Health...

November 2021 127 pages

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Myelodysplastic Syndrome (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome - Drugs In Develop...

November 2021 2188 pages

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Myocardial Fibrosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Fibrosis - Drugs In Development...

November 2021 92 pages

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021

US$ 2,000.00

Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type...

November 2021 256 pages

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021

US$ 3,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules...

November 2021 76 pages

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Non Receptor Tyrosine Protein Kinase TYK2 - Drugs In De...

November 2021 123 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1